Literature DB >> 22085279

Evaluation of cardiomyocyte hypoxia injury models for the pharmacological study in vitro.

Hong-Ming Zhu1, Li Deng.   

Abstract

CONTEXT: Traditional Herbal Medicine (THM) has many advantages that make it a promising choice for the treatment of ischemic heart disease (IHD). To study the mechanism of IHDs or pharmacological actions of THM, many hypoxia-induced cardiomyocyte injury models have been established. Radix Salvia miltorrhiza (Danshen) was used as a representative of THM. Danshen is a famous medicinal herb widely applied in Asia to relieve ischemic cardiovascular diseases.
OBJECTIVE: To investigate the effects of various hypoxic conditions and discuss a suitable hypoxia model, cell viability, apoptosis, release of myocardial injury markers, and mRNA levels of target genes were tested for the first time.
MATERIALS AND METHODS: Radix Salvia miltorrhiza (Danshen) was purchased from a GMP-compliant producer and both its preparation method and quality control were standardized. Cellular status, such as cell viability, apoptosis, releases of myocardial injury markers, and the mRNA level of target gene were tested by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) method, biochemical analyzer, flow cytometry, Hoechst 33258 staining, and real-time PCR, respectively.
RESULTS: Based on our data, we found a treppe response of cardiomyocyte in the hypoxic condition and suggested that 8 h in 2% O2 might be a suitable condition for in vitro pharmacological study of cardiomyocytes. DISCUSSION AND
CONCLUSIONS: Our findings outlined more extended and in-depth capability of cardiomyocyte suffering from hypoxia, and might be of particular interest due to the high prevalence of THM pharmacological study.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22085279     DOI: 10.3109/13880209.2011.583255

Source DB:  PubMed          Journal:  Pharm Biol        ISSN: 1388-0209            Impact factor:   3.503


  2 in total

1.  An Injectable Oxygen Release System to Augment Cell Survival and Promote Cardiac Repair Following Myocardial Infarction.

Authors:  Zhaobo Fan; Zhaobin Xu; Hong Niu; Ning Gao; Ya Guan; Chao Li; Yu Dang; Xiaoyu Cui; Xuanyou Liu Liu; Yunyan Duan; Haichang Li; Xinyu Zhou; Pei-Hui Lin; Jianjie Ma; Jianjun Guan
Journal:  Sci Rep       Date:  2018-01-22       Impact factor: 4.379

2.  MicroRNA-210 suppresses glucocorticoid receptor expression in response to hypoxia in fetal rat cardiomyocytes.

Authors:  Shannalee R Martinez; Qingyi Ma; Chiranjib Dasgupta; Xianmei Meng; Lubo Zhang
Journal:  Oncotarget       Date:  2017-05-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.